Complete Filing Data
Stoke Therapeutics, Inc. reported Stockholders Equity of $352.46 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Stoke Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.9M | -$89.0M | -$104.7M | -$101.1M | -$85.8M | -$52.2M | -$32.3M | -$12.5M |
| Operating Income Loss | -$20.6M | -$101.4M | -$114.8M | -$104.4M | -$86.1M | -$53.0M | -$35.7M | -$12.8M |
| Operating Expenses | $205.0M | $137.9M | $123.6M | $116.8M | $86.1M | $53.0M | $35.7M | $12.8M |
| Research And Development Expense | $137.9M | $89.1M | $82.2M | $77.8M | $54.2M | $32.2M | $23.8M | $8.4M |
| Nonoperating Income Expense | $13.7M | $12.4M | $10.1M | $3.3M | $260.0K | $801.0K | $3.4M | $260.0K |
| Other Nonoperating Income Expense | -$51.0K | -$247.0K | $166.0K | $167.0K | $140.0K | $101.0K | $2.0K | -$10.0K |
| General And Administrative Expense | $48.8M | $41.3M | $38.9M | $31.9M | $20.8M | $11.9M | $4.4M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $694.0K | -$127.0K | $1.2M | -$1.0M | -$168.0K | |||
| Interest Income Expense Nonoperating Net | $13.8M | $12.6M | $9.9M | $3.1M | $120.0K | $700.0K | ||
| Comprehensive Income Net Of Tax | -$6.2M | -$89.1M | -$103.5M | -$102.1M | -$86.0M | -$52.2M | ||
| Other Comprehensive Income Loss Net Of Tax | $694.0K | -$127.0K | $1.2M | -$1.0M | -$168.0K | |||
| Revenues | $184.4M | $36.6M | $8.8M | $12.4M | ||||
| Deferred Revenue Current | $11.9M | $19.0M | $15.3M | $14.9M | ||||
| Deferred Revenue Noncurrent | $7.0M | $33.1M | $36.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$38.3M | -$23.5M | $112.9M | -$26.4M | -$25.7M | -$26.4M | -$24.5M | -$30.7M | -$22.5M | -$26.1M | -$24.7M | -$24.6M | -$22.6M | -$22.0M | -$16.8M | -$14.6M | -$13.7M | -$13.0M | -$11.0M | -$10.2M | -$8.6M | -$7.8M | -$5.7M | -$4.3M | -$3.3M | -$3.0M | -$1.9M |
| Operating Income Loss | -$43.1M | -$27.3M | $111.2M | -$30.0M | -$29.3M | -$28.4M | -$27.2M | -$33.3M | -$24.7M | -$27.1M | -$25.2M | -$24.8M | -$22.7M | -$22.0M | -$16.8M | -$14.6M | -$13.7M | -$13.0M | -$11.7M | -$11.1M | -$9.8M | -$8.4M | -$6.3M | -$4.5M | -$3.3M | -$3.0M | -$1.9M |
| Operating Expenses | $53.7M | $41.1M | $47.3M | $34.9M | $34.2M | $32.6M | $30.5M | $30.8M | $29.8M | $30.1M | $28.5M | $27.8M | $22.7M | $22.0M | $16.8M | $14.6M | $13.7M | $13.0M | $11.7M | $11.1M | $9.8M | $8.4M | $6.3M | $4.5M | $3.3M | $3.0M | $1.9M |
| Research And Development Expense | $37.7M | $25.9M | $32.7M | $22.2M | $21.1M | $22.4M | $20.3M | $20.6M | $19.6M | $20.1M | $18.4M | $18.3M | $14.4M | $14.1M | $9.9M | $8.1M | $8.0M | $7.2M | $6.5M | $6.0M | $4.1M | $2.2M | $1.9M | ||||
| Nonoperating Income Expense | $3.5M | $3.8M | $2.9M | $3.6M | $3.6M | $2.0M | $2.7M | $2.6M | $2.1M | $1.0M | $586.0K | $146.0K | $86.0K | $62.0K | $34.0K | $27.0K | $53.0K | $696.0K | $1.2M | $626.0K | $580.0K | ||||||
| Other Nonoperating Income Expense | $3.0K | $28.0K | $28.0K | $28.0K | -$48.0K | -$428.0K | $41.0K | $41.0K | $42.0K | $42.0K | $42.0K | $42.0K | $42.0K | $28.0K | $28.0K | $28.0K | $14.0K | $22.0K | $2.0K | -$3.0K | |||||||
| General And Administrative Expense | $15.3M | $14.7M | $12.7M | $13.0M | $10.2M | $10.3M | $10.2M | $10.2M | $9.9M | $10.1M | $9.5M | $8.3M | $7.9M | $6.9M | $5.6M | $5.0M | $4.5M | $3.3M | $2.4M | $2.2M | $1.1M | $1.1M | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $350.0K | $200.0K | $47.0K | $181.0K | -$15.0K | $24.0K | $232.0K | $219.0K | $577.0K | -$427.0K | -$592.0K | -$516.0K | $20.0K | -$42.0K | |||||||||||||
| Interest Income Expense Nonoperating Net | $3.5M | $3.8M | $2.9M | $3.5M | $3.7M | $2.4M | $2.7M | $2.6M | $2.1M | $995.0K | $544.0K | $104.0K | $44.0K | $34.0K | $6.0K | -$1.0K | $39.0K | ||||||||||
| Comprehensive Income Net Of Tax | -$38.0M | -$23.3M | $112.9M | -$26.2M | -$25.7M | -$26.4M | -$24.3M | -$30.4M | -$22.0M | -$26.5M | -$25.2M | -$25.2M | -$22.6M | -$22.0M | -$16.8M | -$13.7M | -$13.0M | ||||||||||
| Other Comprehensive Income Loss Net Of Tax | $350.0K | $200.0K | $47.0K | $181.0K | -$15.0K | $24.0K | $232.0K | $219.0K | $577.0K | -$427.0K | -$592.0K | -$516.0K | $20.0K | -$42.0K | |||||||||||||
| Revenues | $10.6M | $13.8M | $158.6M | $4.9M | $4.8M | $4.2M | $3.3M | -$2.5M | $5.2M | $2.9M | $3.2M | $3.0M | |||||||||||||||
| Deferred Revenue Current | $5.8M | $8.7M | $18.2M | $31.6M | $26.1M | $20.9M | $8.7M | $8.1M | $13.5M | $12.8M | $10.6M | $8.5M | |||||||||||||||
| Deferred Revenue Noncurrent | $8.6M | $9.6M | $10.3M | $8.3M | $16.9M | $25.0M | $40.7M | $43.3M | $34.1M | $41.1M | $45.2M | $49.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $352.5M | $229.0M | $159.6M | $184.8M | $217.8M | $286.1M | $224.4M | $105.1M | -$1.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $84.9M | $128.8M | $192.0M | $114.1M | $145.5M | $287.5M | $222.7M | $105.6M | $1.9M |
| Cash And Cash Equivalents At Carrying Value | $84.2M | $128.0M | $191.4M | $113.6M | $144.9M | $287.3M | $222.5M | $105.4M | |
| Restricted Cash Noncurrent | $227.0K | $721.0K | $569.0K | $569.0K | $569.0K | $205.0K | $205.0K | $204.0K | |
| Retained Earnings Accumulated Deficit | -$497.7M | -$490.8M | -$401.8M | -$297.2M | -$196.1M | -$110.3M | -$58.0M | -$25.7M | |
| Property Plant And Equipment Net | $3.1M | $3.9M | $5.8M | $6.7M | $4.1M | $2.7M | $2.5M | $1.2M | |
| Liabilities Noncurrent | $8.1M | $2.5M | $38.0M | $39.8M | $3.9M | $422.0K | $221.0K | $4.0K | |
| Liabilities Current | $57.9M | $40.1M | $30.8M | $31.4M | $17.1M | $11.4M | $4.1M | $2.5M | |
| Liabilities And Stockholders Equity | $418.4M | $271.6M | $228.3M | $256.1M | $238.9M | $297.9M | $228.8M | $107.5M | |
| Liabilities | $66.0M | $42.5M | $68.8M | $71.2M | $21.1M | $11.8M | $4.3M | $2.5M | |
| Interest Receivable Current | $2.0M | $700.0K | $64.0K | $588.0K | $132.0K | $6.0K | $281.0K | $196.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$43.8M | -$63.2M | $77.9M | -$31.3M | -$142.0M | $64.8M | $117.1M | $103.8M | |
| Assets Current | $305.7M | $232.8M | $215.3M | $244.1M | $229.2M | $293.9M | $226.0M | $106.1M | |
| Assets | $418.4M | $271.6M | $228.3M | $256.1M | $238.9M | $297.9M | $228.8M | $107.5M | |
| Accrued And Other Current Liabilities | $41.0M | $18.6M | $13.8M | $15.7M | $14.8M | $9.9M | $3.4M | $1.4M | |
| Accounts Payable Current | $4.9M | $2.5M | $1.7M | $766.0K | $2.4M | $1.5M | $751.0K | $1.1M | |
| Common Stock Value | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | ||
| Operating Lease Right Of Use Asset | $3.1M | $4.3M | $6.6M | $4.8M | $4.9M | $1.1M | |||
| Reduction In Carrying Amount Of Operating Lease Right Of Use Assets | $2.4M | $2.3M | $2.3M | $2.0M | $1.3M | $1.0M | |||
| Available For Sale Securities Debt Securities Current | $200.5M | $88.9M | $10.0M | $116.0M | $74.9M | $0.00 | |||
| Amortization And Accretion Of Marketable Securities | -$1.1M | -$1.6M | -$325.0K | -$211.0K | $143.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $543.0K | -$151.0K | -$24.0K | -$1.2M | -$168.0K | ||||
| Other Liabilities Noncurrent | $1.1M | $2.5M | $4.9M | $3.0M | $3.9M | ||||
| Gain Loss On Sale Of Property Plant Equipment | -$145.0K | -$1.0K | -$29.0K | -$3.0K | -$3.0K | -$10.0K | |||
| Prepaid Expense And Other Assets Current | $6.4M | $3.3M | $548.0K | ||||||
| Other Assets Current | $3.9M | $2.3M | $2.6M | $3.0M | $2.2M | ||||
| Shares Sold As Part Of Controlled Equity Offering Sales Agreement Value | 52.1M | 45.2M | |||||||
| Restricted Cash Current | $494.0K | $75.0K | |||||||
| Deferred Finance Costs Current Net | $117.0K | $181.0K | |||||||
| Right Of Use Assets Recognized In Exchange For Operating Leases | $1.8M | $4.1M | $1.8M | $5.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $308.1M | $334.9M | $350.1M | $232.1M | $242.7M | $140.3M | $173.0M | $190.2M | $213.8M | $204.1M | $224.3M | $240.0M | $237.5M | $255.1M | $272.5M | $192.5M | $203.4M | $214.3M | $233.7M | $241.5M | $99.6M | $19.4M | $9.3M | $12.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $84.1M | $102.3M | $275.6M | $150.6M | $194.0M | $179.2M | $190.5M | $192.6M | $190.9M | $114.0M | $68.3M | $84.7M | $149.8M | $169.3M | $267.7M | $191.7M | $202.1M | $211.5M | $233.3M | $242.9M | $98.9M | $19.4M | $9.6M | ||
| Cash And Cash Equivalents At Carrying Value | $83.4M | $101.5M | $274.8M | $150.0M | $193.5M | $178.6M | $190.0M | $192.1M | $190.3M | $113.4M | $67.8M | $84.1M | $149.0M | $169.1M | $267.5M | $191.5M | $201.9M | $211.3M | $233.0M | $242.7M | $98.7M | $19.4M | $9.5M | ||
| Restricted Cash Noncurrent | $721.0K | $721.0K | $721.0K | $494.0K | $494.0K | $569.0K | $569.0K | $569.0K | $569.0K | $569.0K | $569.0K | $569.0K | $569.0K | $75.0K | $58.0K | $205.0K | $205.0K | $205.0K | $205.0K | $205.0K | |||||
| Retained Earnings Accumulated Deficit | -$439.8M | -$401.4M | -$378.0M | -$480.3M | -$453.9M | -$428.2M | -$374.9M | -$350.3M | -$319.7M | -$271.5M | -$245.4M | -$220.7M | -$171.6M | -$149.0M | -$127.1M | -$95.7M | -$82.0M | -$69.1M | -$47.9M | -$39.3M | |||||
| Property Plant And Equipment Net | $3.1M | $3.3M | $3.6M | $4.3M | $4.8M | $5.3M | $6.2M | $6.5M | $6.8M | $7.2M | $5.9M | $5.0M | $2.9M | $2.9M | $2.7M | $2.9M | $2.8M | $3.0M | $1.9M | $1.7M | |||||
| Liabilities Noncurrent | $10.4M | $10.9M | $12.1M | $11.3M | $20.6M | $29.3M | $41.7M | $44.9M | $36.4M | $44.7M | $49.5M | $53.1M | $4.4M | $1.2M | $333.0K | $665.0K | $1.0M | $1.0M | $228.0K | $18.0K | |||||
| Liabilities Current | $41.7M | $38.7M | $44.7M | $49.9M | $44.5M | $35.6M | $25.2M | $21.8M | $31.5M | $28.8M | $27.6M | $22.9M | $11.9M | $8.2M | $6.1M | $6.7M | $5.8M | $5.5M | $4.9M | $4.8M | |||||
| Liabilities And Stockholders Equity | $360.3M | $384.5M | $406.9M | $293.3M | $307.8M | $205.2M | $239.9M | $256.9M | $281.8M | $277.6M | $301.4M | $315.9M | $253.8M | $264.5M | $278.9M | $199.9M | $210.2M | $220.8M | $238.8M | $246.4M | |||||
| Liabilities | $52.2M | $49.6M | $56.8M | $61.2M | $65.0M | $64.8M | $66.9M | $66.7M | $68.0M | $73.5M | $77.1M | $76.0M | $16.3M | $9.4M | $6.4M | $7.4M | $6.8M | $6.5M | $5.1M | $4.8M | |||||
| Interest Receivable Current | $1.6M | $1.6M | $606.0K | $691.0K | $305.0K | $11.0K | $96.0K | $136.0K | $492.0K | $395.0K | $350.0K | $265.0K | $45.0K | $131.0K | $6.0K | $2.0K | $9.0K | $144.0K | $376.0K | $260.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $146.8M | -$12.9M | $76.8M | -$60.8M | -$19.8M | -$11.2M | -$6.7M | ||||||||||||||||||
| Assets Current | $272.4M | $270.0M | $375.7M | $253.6M | $297.0M | $193.3M | $230.0M | $246.2M | $270.2M | $264.6M | $289.2M | $305.8M | $244.9M | $260.2M | $275.3M | $195.5M | $205.5M | $215.8M | $236.7M | $244.4M | |||||
| Assets | $360.3M | $384.5M | $406.9M | $293.3M | $307.8M | $205.2M | $239.9M | $256.9M | $281.8M | $277.6M | $301.4M | $315.9M | $253.8M | $264.5M | $278.9M | $199.9M | $210.2M | $220.8M | $238.8M | $246.4M | |||||
| Accrued And Other Current Liabilities | $30.1M | $25.6M | $24.3M | $15.8M | $14.5M | $12.6M | $13.4M | $12.2M | $13.8M | $14.0M | $13.4M | $11.1M | $11.2M | $7.2M | $4.6M | $5.6M | $4.9M | $3.7M | $3.1M | $3.6M | |||||
| Accounts Payable Current | $5.9M | $4.3M | $2.2M | $2.5M | $3.9M | $2.1M | $3.1M | $1.6M | $4.3M | $1.9M | $3.6M | $3.3M | $655.0K | $963.0K | $1.5M | $1.1M | $904.0K | $1.8M | $1.8M | $1.2M | |||||
| Common Stock Value | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |||||
| Operating Lease Right Of Use Asset | $3.7M | $3.2M | $3.8M | $4.9M | $5.5M | $6.1M | $3.1M | $3.6M | $4.2M | $5.3M | $5.8M | $4.6M | $5.3M | $1.3M | $844.0K | $1.4M | $1.6M | $1.9M | |||||||
| Reduction In Carrying Amount Of Operating Lease Right Of Use Assets | $599.0K | $550.0K | $550.0K | $377.0K | $271.0K | $253.0K | |||||||||||||||||||
| Available For Sale Securities Debt Securities Current | $164.9M | $146.2M | $82.5M | $89.2M | $88.5M | $24.7M | $39.4M | $63.3M | $138.3M | $207.9M | $209.1M | $87.1M | $82.2M | ||||||||||||
| Amortization And Accretion Of Marketable Securities | -$494.0K | -$24.0K | $32.0K | $235.0K | |||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $446.0K | $96.0K | -$104.0K | $166.0K | -$15.0K | -$147.0K | -$379.0K | -$598.0K | -$1.7M | -$1.3M | -$684.0K | -$22.0K | -$42.0K | ||||||||||||
| Other Liabilities Noncurrent | $1.9M | $1.3M | $1.9M | $3.1M | $3.6M | $4.2M | $959.0K | $1.6M | $2.3M | $3.6M | $4.2M | $3.5M | |||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$29.0K | -$3.0K | -$3.0K | ||||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $12.6M | $13.2M | $12.3M | $9.2M | $8.5M | $8.6M | $7.5M | $3.6M | $3.5M | $4.3M | $3.3M | $1.5M | |||||||||||||
| Other Assets Current | $5.5M | $6.9M | $5.0M | $3.8M | $4.3M | $3.6M | $4.3M | $3.7M | $5.9M | ||||||||||||||||
| Shares Sold As Part Of Controlled Equity Offering Sales Agreement Value | 7.7M | 1.3M | 44.7M | 3.1M | 42.1M | ||||||||||||||||||||
| Restricted Cash Current | $0.00 | $75.0K | $75.0K | $75.0K | $75.0K | $147.0K | $147.0K | $147.0K | |||||||||||||||||
| Deferred Finance Costs Current Net | $117.0K | $117.0K | $117.0K | $378.0K | $77.0K | ||||||||||||||||||||
| Right Of Use Assets Recognized In Exchange For Operating Leases |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $32.2M | $27.5M | $25.3M | $22.9M | $16.5M | $5.8M | $1.9M | $240.0K |
| Proceeds From Stock Options Exercised | $8.6M | $1.7M | $371.0K | $494.0K | $777.0K | $2.8M | $315.0K | $19.0K |
| Payments To Acquire Property Plant And Equipment | $670.0K | $203.0K | $1.6M | $4.0M | $1.2M | $1.1M | $1.6M | $935.0K |
| Net Cash Provided By Used In Operating Activities | $45.6M | -$86.9M | -$81.1M | -$31.9M | -$66.9M | -$42.2M | -$31.1M | -$11.0M |
| Net Cash Provided By Used In Investing Activities | -$186.8M | -$107.5M | $105.9M | -$45.9M | -$76.4M | -$1.1M | -$1.6M | -$925.0K |
| Net Cash Provided By Used In Financing Activities | $97.4M | $131.1M | $53.0M | $46.4M | $1.3M | $108.1M | $149.8M | $115.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $545.0K | $1.8M | -$529.0K | $5.2M | $2.9M | $2.9M | $2.0M | $632.0K |
| Proceeds From Stock Plans | $1.0M | $532.0K | $555.0K | $570.0K | $509.0K | $352.0K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$3.5M | $2.9M | $5.2M | $891.0K | $1.7M | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $136.6M | $60.0M | $107.6M | $159.4M | $12.0M | |||
| Increase Decrease In Deferred Revenue | -$130.0K | -$29.4M | -$3.4M | $51.7M | ||||
| Payments To Acquire Marketable Securities | $322.7M | $167.3M | $0.00 | $201.3M | $87.2M | |||
| Increase Decrease In Accounts Payable Accrued Liabilities And Opertaing Leases | $21.3M | $3.1M | -$3.2M | -$3.5M | ||||
| Proceeds From Payments For Other Financing Activities | $0.00 | $1.0K | -$2.0K | -$2.0K | -$2.0K | |||
| Proceeds From Controlled Equity Offering Sales Agreement | $52.1M | $45.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $6.8M | $5.4M | $5.9M | $5.0M | $2.7M | $754.0K | $181.0K |
| Proceeds From Stock Options Exercised | $1.0M | $250.0K | $158.0K | $93.0K | $371.0K | $199.0K | $74.0K |
| Payments To Acquire Property Plant And Equipment | $152.0K | $12.0K | $165.0K | $841.0K | $204.0K | $610.0K | $92.0K |
| Net Cash Provided By Used In Operating Activities | $131.8M | -$24.6M | -$21.4M | $32.5M | -$20.1M | -$10.8M | -$6.5M |
| Net Cash Provided By Used In Investing Activities | $13.6M | $10.0M | $53.1M | -$135.8M | -$204.0K | -$610.0K | -$90.0K |
| Net Cash Provided By Used In Financing Activities | $1.4M | $1.7M | $45.1M | $42.5M | $546.0K | $198.0K | -$68.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.6M | $349.0K | $2.1M | $3.3M | $1.1M | $924.0K | $796.0K |
| Proceeds From Stock Plans | $370.0K | $168.0K | $153.0K | $169.0K | $175.0K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $351.0K | -$3.4M | -$5.5M | -$11.0K | -$265.0K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $32.8M | $10.0M | $53.3M | $9.0M | |||
| Increase Decrease In Deferred Revenue | $9.4M | -$2.4M | -$4.1M | $58.0M | |||
| Payments To Acquire Marketable Securities | $19.0M | $143.9M | |||||
| Increase Decrease In Accounts Payable Accrued Liabilities And Opertaing Leases | $4.7M | -$1.9M | $351.0K | ||||
| Proceeds From Payments For Other Financing Activities | |||||||
| Proceeds From Controlled Equity Offering Sales Agreement | $1.3M | $44.7M | $42.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$1.65 | -$2.38 | -$2.60 | -$2.34 | -$1.56 | -$1.80 | -$17.65 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 278.5M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 58.9M | 54.0M | 45.9M | 39.4M | 36.9M | 36.6M | 32.9M | 727.4K |
| Common Stock Shares Issued | 58.9M | 54.0M | 45.9M | 39.4M | 36.9M | 36.6M | 32.9M | 727.4K |
| Weighted Average Number Of Shares Outstanding Basic | 59.2M | 54.0M | 44.0M | 38.9M | 36.7M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 59.2M | 54.0M | 44.0M | 38.9M | 36.7M | |||
| Earnings Per Share Basic | $-0.12 | $-1.65 | $-2.38 | $-2.60 | $-2.34 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 36.7M | 33.5M | 18.0M | 709.3K | ||||
| Preferred Stock Shares Authorized | 10.0M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.65 | -$0.40 | $1.90 | -$0.47 | -$0.46 | -$0.57 | -$0.55 | -$0.69 | -$0.53 | -$0.66 | -$0.63 | -$0.66 | -$0.60 | -$0.60 | -$0.46 | -$0.42 | -$0.41 | -$0.39 | -$0.34 | -$0.31 | -$0.26 | -$1.54 | -$6.89 | -$6.05 | -$4.75 | -$4.36 | -$2.78 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 55.1M | 54.7M | 54.6M | 52.9M | 52.3M | 46.5M | 44.3M | 44.2M | 44.2M | 39.4M | 39.4M | 39.0M | 36.8M | 36.7M | 36.7M | 33.4M | 33.2M | 33.0M | 32.7M | 32.7M | |||||||
| Common Stock Shares Issued | 55.1M | 54.7M | 54.6M | 52.9M | 52.3M | 46.5M | 44.3M | 44.2M | 44.2M | 39.4M | 39.4M | 39.0M | 36.8M | 36.7M | 36.7M | 33.4M | 33.2M | 33.0M | 32.7M | 32.7M | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 58.6M | 58.4M | 57.9M | 56.3M | 55.8M | 46.2M | 44.3M | 44.2M | 42.5M | 39.4M | 39.3M | 37.4M | 36.8M | 36.7M | |||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 58.6M | 58.4M | 59.4M | 56.3M | 55.8M | 46.2M | 44.3M | 44.2M | 42.5M | 39.4M | 39.3M | 37.4M | 36.7M | 36.7M | |||||||||||||
| Earnings Per Share Basic | $-0.65 | $-0.40 | $1.95 | $-0.47 | $-0.46 | $-0.57 | $-0.55 | $-0.69 | $-0.53 | $-0.66 | $-0.63 | $-0.66 | $-0.61 | $-0.60 | |||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.4M | 36.8M | 36.7M | 36.6M | 33.3M | 33.1M | 32.9M | 32.7M | 5.1M | 833.5K | 699.0K | 691.2K | |||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $32.2M | $27.5M | $25.3M | $22.9M | $16.5M | $5.8M | $1.9M | $240.0K |
| Stock Issued During Period Value Stock Options Exercised | $8.6M | $1.7M | $371.0K | $494.0K | $777.0K | $2.8M | $314.0K | $19.0K |
| Depreciation | $1.8M | $2.2M | $2.5M | $1.5M | $974.0K | $888.0K | $450.0K | $214.0K |
| Additional Paid In Capital | $849.6M | $720.0M | $561.4M | $483.2M | $414.0M | $396.4M | $282.5M | $130.8M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.0M | $532.0K | $555.0K | $570.0K | $509.0K | $352.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $482.0K | $61.0K | $0.00 | $121.0K | $1.3M | $6.0K | $140.0K | $19.0K |
| Prepaid Expense Current | $8.7M | $11.1M | $11.3M | $10.9M | $6.9M | |||
| Investment Income Interest | $744.0K | $3.4M | $270.0K | |||||
| Stock Issued During Period Shares Stock Options Exercised | 1.0M | 828.2K | 145.9K | 270.4K | 287.6K | 841.5K | 382.1K | 57.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.0M | $7.6M | $6.8M | $7.5M | $7.4M | $5.4M | $6.6M | $6.8M | $5.9M | $5.9M | $6.2M | $5.0M | $4.6M | $4.5M | $2.7M | $1.8M | $1.6M | $754.0K | $731.0K | $298.0K | $181.0K | $40.0K | $77.0K | $4.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.5M | $554.0K | $1.0M | $139.0K | $766.0K | $250.0K | $161.0K | $48.0K | $158.0K | $33.0K | $326.0K | $93.0K | $73.0K | $161.0K | $371.0K | $682.0K | $368.0K | $199.0K | $20.0K | $27.0K | $74.0K | $7.0K | $8.0K | |
| Depreciation | $477.0K | $563.0K | $597.0K | $247.0K | $236.0K | $193.0K | $80.0K | |||||||||||||||||
| Additional Paid In Capital | $747.4M | $736.3M | $728.1M | $712.3M | $696.6M | $568.6M | $548.0M | $540.9M | $534.1M | $477.3M | $471.0M | $461.4M | $409.2M | $404.1M | $399.5M | $288.2M | $285.4M | $283.4M | $281.6M | $280.8M | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $632.0K | $370.0K | $364.0K | $168.0K | $401.0K | $153.0K | $401.0K | $169.0K | $334.0K | $175.0K | $352.0K | |||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $27.0K | $6.0K | $545.0K | $301.0K | $97.0K | $35.0K | $198.0K | |||||||||||||||||
| Prepaid Expense Current | $7.7M | $13.7M | $12.7M | $9.8M | $10.3M | $10.7M | $10.9M | $11.0M | $10.2M | |||||||||||||||
| Investment Income Interest | $18.0K | $11.0K | $50.0K | $674.0K | $1.2M | $629.0K | $580.0K | |||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.